Rexahn Pharmaceuticals In-Licenses Breakthrough Oncology Drug Delivery Platform
17 July 2013 - 10:00PM
Business Wire
Maximizes efficacy and minimizes toxicity of
currently marketed anti-cancer drugs
RX-21101 identified as first development
candidate from platform
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Rexahn Pharmaceuticals, Inc. (American Stock Exchange): 0 recent articles
More Rexahn Pharmaceuticals, Inc. News Articles